Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 34.89% is in line with its 5-year average of 36.64%, near the high end of its 5-year range (-135.83%–42.94%).
0.01% below its 12-month average of 34.89%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
34.89%
NET PROFIT MARGIN AVG TTM
34.89%
NET PROFIT MARGIN AVG 3Y
36.49%
NET PROFIT MARGIN AVG 5Y
36.64%
NET PROFIT MARGIN AVG 10Y
31.78%
NET PROFIT MARGIN AVG 15Y
15.45%
NET PROFIT MARGIN AVG 20Y
-29.18%
CURRENT VS TTM AVG
-0.01%
CURRENT VS 3Y AVG
-4.38%
CURRENT VS 5Y AVG
-4.78%
CURRENT VS 10Y AVG
+9.78%
CURRENT VS 15Y AVG
+125.90%
CURRENT VS 20Y AVG
+219.58%
SECTOR MEDIAN · HEALTHCARE
8.98%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+288.53%
vs the sector median at left
Vertex Pharmaceuticals Incorporated
Market Cap
$132.77B
Net Profit Margin
34.89%
TTM Avg
34.89%
3Y Avg
36.49%
5Y Avg
36.64%
Market Cap
$131.80B
Net Profit Margin
18.87%
TTM Avg
-1.95%
3Y Avg
6.91%
5Y Avg
3.60%
Market Cap
$124.01B
Net Profit Margin
28.45%
TTM Avg
28.09%
3Y Avg
25.67%
5Y Avg
26.14%
Market Cap
$143.94B
Net Profit Margin
15.95%
TTM Avg
15.52%
3Y Avg
19.51%
5Y Avg
19.37%
Market Cap
$121.44B
Net Profit Margin
1.18%
TTM Avg
0.84%
3Y Avg
1.34%
5Y Avg
1.79%
Market Cap
$118.47B
Net Profit Margin
13.93%
TTM Avg
13.55%
3Y Avg
12.62%
5Y Avg
13.06%
Market Cap
$104.89B
Net Profit Margin
1.12%
TTM Avg
1.05%
3Y Avg
1.09%
5Y Avg
0.48%
Market Cap
$104.82B
Net Profit Margin
14.43%
TTM Avg
13.09%
3Y Avg
13.60%
5Y Avg
12.87%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated (VRTX) | $132.77B | 34.89% | 34.89% | 36.49% | 36.64% |
| Bristol-Myers Squibb Company (BMY)vs › | $131.80B | 18.87% | -1.95% | 6.91% | 3.60% |
| Intuitive Surgical, Inc. (ISRG)vs › | $124.01B | 28.45% | 28.09% | 25.67% | 26.14% |
| Danaher Corporation (DHR)vs › | $143.94B | 15.95% | 15.52% | 19.51% | 19.37% |
| CVS Health Corp. (CVS)vs › | $121.44B | 1.18% | 0.84% | 1.34% | 1.79% |
| Medtronic plc (MDT)vs › | $118.47B | 13.93% | 13.55% | 12.62% | 13.06% |
| Pfizer Inc. (PFE)vs › | $158.76B | 6.81% | 12.51% | 14.97% | 18.18% |
| McKesson Corporation (MCK)vs › | $104.89B | 1.12% | 1.05% | 1.09% | 0.48% |
| Stryker Corporation (SYK)vs › | $104.82B | 14.43% | 13.09% | 13.60% | 12.87% |
| Sanofi (SNY)vs › | $103.25B | 8.10% | 14.63% | 15.72% | 18.61% |
Operating Margin
38.6%
Net Profit Margin
34.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 32.99% |
| 2026-03-31 | 34.53% |
| 2025-12-31 | 36.91% |
| 2025-09-30 | 35.20% |
| 2025-06-30 | 34.84% |
| 2025-03-31 | 23.33% |
| 2024-12-31 | 31.35% |
| 2024-09-30 | 37.71% |
| 2024-06-30 | -135.83% |
| 2024-03-31 | 40.92% |
| 2023-12-31 | 38.48% |
| 2023-09-30 | 41.69% |
| 2023-06-30 | 36.73% |
| 2023-03-31 | 29.47% |
| 2022-12-31 | 35.56% |
| 2022-09-30 | 39.86% |
| 2022-06-30 | 36.90% |
| 2022-03-31 | 36.33% |
| 2021-12-31 | 37.16% |
| 2021-09-30 | 42.94% |
| 2021-06-30 | 3.73% |
| 2021-03-31 | 37.88% |
| 2020-12-31 | 37.12% |
| 2020-09-30 | 43.39% |
| 2020-06-30 | 54.92% |
| 2020-03-31 | 39.78% |
| 2019-12-31 | 41.27% |
| 2019-09-30 | 6.06% |
| 2019-06-30 | 28.41% |
| 2019-03-31 | 31.29% |
| 2018-12-31 | 178.20% |
| 2018-09-30 | 16.41% |
| 2018-06-30 | 27.57% |
| 2018-03-31 | 32.81% |
| 2017-12-31 | 15.45% |
| 2017-09-30 | -17.81% |
| 2017-06-30 | 3.31% |
| 2017-03-31 | 34.66% |
| 2016-12-31 | 7.18% |
| 2016-09-30 | -10.11% |
| 2016-06-30 | -14.95% |
| 2016-03-31 | -10.46% |
| 2015-12-31 | -18.07% |
| 2015-09-30 | -30.71% |
| 2015-06-30 | -113.71% |
| 2015-03-31 | -143.39% |
| 2014-12-31 | -122.21% |
| 2014-09-30 | -95.01% |
| 2014-06-30 | -115.14% |
| 2014-03-31 | -196.25% |
| 2013-12-31 | 12.61% |
| 2013-09-30 | -55.99% |
| 2013-06-30 | -18.40% |
| 2013-03-31 | -93.80% |
| 2012-12-31 | -22.80% |
| 2012-09-30 | -17.13% |
| 2012-06-30 | -15.52% |
| 2012-03-31 | 20.88% |
| 2011-12-31 | 28.16% |
| 2011-09-30 | 33.54% |
| 2011-06-30 | -152.13% |
| 2011-03-31 | -239.06% |
| 2010-12-31 | -275.31% |
| 2010-09-30 | -878.16% |
| 2010-06-30 | -632.49% |
| 2010-03-31 | -736.86% |
| 2009-12-31 | -468.13% |
| 2009-09-30 | -599.29% |
| 2009-06-30 | -898.54% |
| 2009-03-31 | -678.39% |
| 2008-12-31 | -433.79% |
| 2008-09-30 | -411.41% |
| 2008-06-30 | -131.57% |
| 2008-03-31 | -230.72% |
| 2007-12-31 | -168.17% |
| 2007-09-30 | -260.97% |
| 2007-06-30 | -308.32% |
| 2007-03-31 | -117.32% |
| 2006-12-31 | -29.01% |
| 2006-09-30 | -97.21% |
| 2006-06-30 | -261.25% |
| 2006-03-31 | -128.14% |
| 2005-12-31 | -59.81% |
| 2005-09-30 | -219.79% |
| 2005-06-30 | -126.82% |
| 2005-03-31 | -156.33% |
| 2004-12-31 | -107.37% |
| 2004-09-30 | -144.52% |
| 2004-06-30 | -238.76% |
| 2004-03-31 | -230.90% |
| 2003-12-31 | -386.92% |
| 2003-09-30 | -470.91% |
| 2003-06-30 | -260.57% |
| 2003-03-31 | 91.16% |
| 2002-12-31 | -73.28% |
| 2002-09-30 | -97.60% |
